- 22305376OWN - NLMSTAT- MEDLINEDA  - 20120206DCOM- 20120523IS  - 1557-3117 (Electronic)IS  - 1053-2498 (Linking)VI  - 31IP  - 2DP  - 2012 FebTI  - The Fourth INTERMACS Annual Report: 4,000 implants and counting.PG  - 117-26LID - 10.1016/j.healun.2011.12.001 [doi]AB  - The Fourth Annual Report of the Interagency Registry for Mechanically Assisted      Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of      patient and data collection. With more than 4,000 patients entered into the      database, the evolution of pump technology, strategy at implant, and pre-implant       patient profiles are chronicled. A risk factor analysis of the entire adult      primary implant population is provided, and the recent composition of patient      profiles is examined. Current actuarial survival with continuous-flow pumps      exceeds 80% at 1 year and 70% at 2 years.CI  - Copyright (c) 2012. Published by Elsevier Inc.FAU - Kirklin, James KAU  - Kirklin JKAD  - Division of Cardiovascular, University of Alabama at Birmingham, Birmingham,      Alabama 35294, USA. jkirklin@uab.eduFAU - Naftel, David CAU  - Naftel DCFAU - Kormos, Robert LAU  - Kormos RLFAU - Stevenson, Lynne WAU  - Stevenson LWFAU - Pagani, Francis DAU  - Pagani FDFAU - Miller, Marissa AAU  - Miller MAFAU - Baldwin, J TimothyAU  - Baldwin JTFAU - Young, James BAU  - Young JBLA  - engGR  - HHSN268201100025C/PHS HHS/United StatesPT  - Journal ArticlePT  - Research Support, N.I.H., ExtramuralPL  - United StatesTA  - J Heart Lung TransplantJT  - The Journal of heart and lung transplantation : the official publication of the      International Society for Heart TransplantationJID - 9102703SB  - IMMH  - *Annual Reports as TopicMH  - FemaleMH  - Heart Failure/mortality/surgeryMH  - Heart Transplantation/mortality/statistics & numerical dataMH  - Heart-Assist Devices/*utilizationMH  - HumansMH  - *Interinstitutional RelationsMH  - MaleMH  - Middle AgedMH  - National Heart, Lung, and Blood Institute (U.S.)MH  - Registries/*statistics & numerical dataMH  - Risk FactorsMH  - Survival RateMH  - Treatment OutcomeMH  - United States/epidemiologyMH  - United States Food and Drug AdministrationEDAT- 2012/02/07 06:00MHDA- 2012/05/24 06:00CRDT- 2012/02/07 06:00PHST- 2011/12/20 [received]PHST- 2011/12/28 [accepted]AID - S1053-2498(11)01250-2 [pii]AID - 10.1016/j.healun.2011.12.001 [doi]PST - ppublishSO  - J Heart Lung Transplant. 2012 Feb;31(2):117-26. doi:      10.1016/j.healun.2011.12.001.